India is ready to step in as an alternative site for early-stage clinical trials to help mitigate the impact of disruptions ...

Regarding patients with HER2-negative, estrogen receptor (ER)-positive breast cancer, the phase 3 KEYNOTE-756 study is ...

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing ...

Experts discuss the crucial role of government in enhancing India's participation in clinical trials at BioAsia 2025 panel.

We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...

Safety Review Committee Found No Safety Concerns Following Milestone Trial TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" ...

London researchers launched a study in 2019 to see if the beneficial poop microbes could improve the effectiveness of ...

Initiated the Phase 3 VELA program of the Nanobody ® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa ...

"The efforts over the past year by the team at Keros have positioned us to continue to advance our promising pipeline of ...

Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV ...

Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first ...